Rudolf Schneider

Person

Niedernhausen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
PIM-3 kinase as a target for type 2 diabetes mellitus
- Patent number 8,580,251
- Issue date Nov 12, 2013
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Glimepiride- and insulin-induced glycosylphosphatidylinositol-speci...
- Patent number 8,017,350
- Issue date Sep 13, 2011
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PIM-3 kinase as a target for type 2 diabetes mellitus
- Patent number 7,629,126
- Issue date Dec 8, 2009
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Phosophoinositoglycan binding proteins
- Patent number 7,449,560
- Issue date Nov 11, 2008
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PIM-3 kinase as a target for type 2 diabetes mellitus
- Patent number 7,227,006
- Issue date Jun 5, 2007
- Sanofi-Aventis Deutschland GmbH
- Marcus Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Phosophoinositoglycan binding proteins
- Patent number 7,049,416
- Issue date May 23, 2006
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PIM-3 Kinase as a Target for Type 2 Diabetes Mellitus
- Publication number 20140087969
- Publication date Mar 27, 2014
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS
- Publication number 20100041058
- Publication date Feb 18, 2010
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS
- Publication number 20070154919
- Publication date Jul 5, 2007
- Sanofi-Aventis Deutschland GmbH
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLIMEPIRIDE- AND INSULIN-INDUCED GLYCOSYLPHOSPHATIDYLINOSITOL-SPECI...
- Publication number 20070111263
- Publication date May 17, 2007
- Sanofi-Aventis Deutschland GmbH
- Guenter MUELLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phosophoinositoglycan binding proteins
- Publication number 20060160142
- Publication date Jul 20, 2006
- Sanofi-Aventis Deutschland GmbH
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Phosophoinositoglycan binding proteins
- Publication number 20040229278
- Publication date Nov 18, 2004
- Guenter Mueller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIM-3 kinase as a target for type 2 diabetes mellitus
- Publication number 20040038246
- Publication date Feb 26, 2004
- Marc Korn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Rudolf Schneider

Person

Patents Grantslast 30 patents

PIM-3 kinase as a target for type 2 diabetes mellitus

Glimepiride- and insulin-induced glycosylphosphatidylinositol-speci...

PIM-3 kinase as a target for type 2 diabetes mellitus

Phosophoinositoglycan binding proteins

PIM-3 kinase as a target for type 2 diabetes mellitus

Phosophoinositoglycan binding proteins

Patents Applicationslast 30 patents

PIM-3 Kinase as a Target for Type 2 Diabetes Mellitus

PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS

PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS

GLIMEPIRIDE- AND INSULIN-INDUCED GLYCOSYLPHOSPHATIDYLINOSITOL-SPECI...

Phosophoinositoglycan binding proteins

Phosophoinositoglycan binding proteins

PIM-3 kinase as a target for type 2 diabetes mellitus